Monday ،Jul 4, 2022، 01:24

News

Helal Iran Medical Devices Co. develops joint cooperation with  knowledge-based Granule Masoum company
With the aim of boosting as well as maintaining bilateral cooperation, managing director along with Board members of Helal Iran Medical Devices Co.
3 July 2022
MPO's managing director visits IROST
Dr. Alireza Askari, MPO's managing director, and his accompanying delegation met the president of Iranian research organization for science &
6 June 2022
Soha Helal Distribution Co. opens its 16th distribution center
The 16th distribution center of Soha Helal Distribution Co. was opened in east of Tehran, MPO's managing director announced
28 May 2022
Soha Pharmaceutical Co. manufactured more than 16 million pharmaceuticals in April
Soha Pharmaceutical Co. has manufactured more than 16 million pharmaceutical items in different dosage forms (including 11/600/000 tablets, 3/800/000
21 May 2022
Page 1 From 13

Medicine News

This ninth update of WHO’s guideline on therapeutics includes a recommendation that casirivimab-imdevimab not be used for patients infected with the Omicron variant
WHO has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how widely available and affordable they will be.
On 26 November 2021, WHO designated the variant B.1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). This decision was based on the evidence presented to the TAG-VE that Omicron has several mutations that may have an impact on how it behaves, for example, on how easily it spreads or the severity of illness it causes. Here is a summary of what is currently known.
WHO lists 9th COVID-19 vaccine for emergency use with aim to increase access to vaccination in lower-income countries
Page 1 From 7

Photo Gallery

نقشه جدید